Ameliorative effects of the traditional Chinese medicine formula Qing-Mai-Yin on arteriosclerosis obliterans in a rabbit model

Context Qing-Mai-Yin (QMY) is a clinically used herbal formula for treating arteriosclerosis obliterans (ASO). Objective To evaluate the chemical constituents and effects of QMY on ASO rabbit model. Materials and methods Forty-eight New Zealand rabbits were divided into six groups (n = 8): normal (n...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei Zhang (Author), Jia-Qin Yuan (Author), Fu-Chen Song (Author), Mei-Dong Zhu (Author), Qi Li (Author), Sheng-Hua Liu (Author), Kai Zhao (Author), Cheng Zhao (Author)
Format: Book
Published: Taylor & Francis Group, 2020-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_fbd3465367524e5fb0cb5716b64b96b8
042 |a dc 
100 1 0 |a Lei Zhang  |e author 
700 1 0 |a Jia-Qin Yuan  |e author 
700 1 0 |a Fu-Chen Song  |e author 
700 1 0 |a Mei-Dong Zhu  |e author 
700 1 0 |a Qi Li  |e author 
700 1 0 |a Sheng-Hua Liu  |e author 
700 1 0 |a Kai Zhao  |e author 
700 1 0 |a Cheng Zhao  |e author 
245 0 0 |a Ameliorative effects of the traditional Chinese medicine formula Qing-Mai-Yin on arteriosclerosis obliterans in a rabbit model 
260 |b Taylor & Francis Group,   |c 2020-01-01T00:00:00Z. 
500 |a 1388-0209 
500 |a 1744-5116 
500 |a 10.1080/13880209.2020.1803368 
520 |a Context Qing-Mai-Yin (QMY) is a clinically used herbal formula for treating arteriosclerosis obliterans (ASO). Objective To evaluate the chemical constituents and effects of QMY on ASO rabbit model. Materials and methods Forty-eight New Zealand rabbits were divided into six groups (n = 8): normal (normal rabbits treated with 0.5% CMC-Na), vehicle (ASO rabbits treated with 0.5% CMC-Na), positive (simvastatin, 1.53 mg/kg), and QMY treatment (300, 600, and 1200 mg/kg). ASO rabbit model was prepared by high fatty feeding, roundly shortening artery, and bovine serum albumin immune injury. QMY (300, 600 and 1200 mg/kg) was orally administered for 8 weeks. The effects and possible mechanisms of QMY on ASO rabbits were evaluated by pathological examination, biochemical assays, and immunohistochemical assays. The compositions of QMY were analysed using HPLC-Q-TOF-MS/MS analysis. Results Compared to the vehicle rabbit, QMY treatment suppressed plaque formation and intima thickness in aorta, and decreased intima thickness, whereas increased lumen area of femoral artery. Additionally, QMY treatment decreased TC, TG and LDL, decreased CRP and ET, and increased NO and 6-K-PGF1α in serum. Furthermore, the potential mechanisms studied revealed that QMY treatment could suppress expression of TNF-α, IL-6, ICAM-1 and NF-κB in endothelial tissues, and increase IκB. In addition, HPLC analysis showed QMY had abundant anthraquinones, stilbenes, and flavonoids. Conclusion QMY has ameliorative effects on ASO rabbit, and the potential mechanisms are correlated to reducing inflammation and down-regulating NF-κB. Our study provides a scientific basis for the future application and investigation of QMY. 
546 |a EN 
690 |a inflammatory reactions 
690 |a nf-κb signal 
690 |a hplc-q-tof-ms/ms 
690 |a mechanisms 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Pharmaceutical Biology, Vol 58, Iss 1, Pp 785-795 (2020) 
787 0 |n http://dx.doi.org/10.1080/13880209.2020.1803368 
787 0 |n https://doaj.org/toc/1388-0209 
787 0 |n https://doaj.org/toc/1744-5116 
856 4 1 |u https://doaj.org/article/fbd3465367524e5fb0cb5716b64b96b8  |z Connect to this object online.